Anti-tumour necrosis factor therapy is a risk factor for certain subtypes of chronic rhinosinusitis

被引：0
|
作者：
Leonard, C. G.
Masih, C.
McDonald, S.
Taylor, G.
Maiden, N.
Leyden, P. J.
机构：
来源：
IRISH JOURNAL OF MEDICAL SCIENCE | 2016年 / 185卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：S148 / S148
页数：1
相关论文
共 50 条
  • [1] Anti-tumour necrosis factor therapy is associated with certain subtypes of chronic rhinosinusitis
    Leonard, C. G.
    Masih, C.
    McDonald, S.
    Taylor, G.
    Maiden, N.
    Leyden, P. J.
    JOURNAL OF LARYNGOLOGY AND OTOLOGY, 2016, 130 (06) : 560 - 564
  • [2] Anti-tumour necrosis factor therapy in seronegative spondyloarthritis
    Swales, C
    Bowness, P
    CLINICAL MEDICINE, 2005, 5 (03) : 219 - 222
  • [3] Anti-tumour necrosis factor therapy in the West Midlands
    Bartram, D
    Sheeran, T
    Price, T
    Mulherin, D
    RHEUMATOLOGY, 2004, 43 (03) : 400 - 400
  • [4] Anti-tumour necrosis factor (TNF)-α therapy (etanercept)
    Maya Buch
    Arthritis Research & Therapy, 4 (1)
  • [5] Optic neuritis occurring with anti-tumour necrosis factor α therapy
    Simsek, Ismail
    Erdem, Hakan
    Pay, Salih
    Sobaci, Gungor
    Dinc, Ayhan
    ANNALS OF THE RHEUMATIC DISEASES, 2007, 66 (09) : 1255 - 1258
  • [6] Problems encountered during anti-tumour necrosis factor therapy
    Desai, Sheetal B.
    Furst, Daniel E.
    BEST PRACTICE & RESEARCH IN CLINICAL RHEUMATOLOGY, 2006, 20 (04): : 757 - 790
  • [7] The safety of anti-tumour necrosis factor therapy in rheumatoid arthritis
    Askling, Johan
    Dixon, Will
    CURRENT OPINION IN RHEUMATOLOGY, 2008, 20 (02) : 138 - 144
  • [8] Demyelination during anti-tumour necrosis factor therapy for psoriasis
    Boggs, J. M. E.
    Barnes, L.
    CLINICAL AND EXPERIMENTAL DERMATOLOGY, 2018, 43 (05) : 577 - 578
  • [9] Retention on anti-tumour necrosis factor therapy: the Waikato experience
    Ip, Ken
    Hartley, Lorraine
    Solanki, Kamal
    White, Douglas
    NEW ZEALAND MEDICAL JOURNAL, 2015, 128 (1415) : 34 - 40
  • [10] Anti-Tumour Necrosis Factor Therapy for Ulcerative ColitisEvidence to Date
    Chandrashekhar Thukral
    Adam Cheifetz
    Mark A. Peppercorn
    Drugs, 2006, 66 : 2059 - 2065
12345